Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Wölkart

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Cardiovascular Research|November 14, 2003
Peroxynitrite-induced cardiac depression: role of myofilament desensitization and cGMP pathwayFriedrich Brunner, Gerald Wölkart
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080)Friedrich Brunner, Gerald Wölkart, Stephen Haleen
Atherosclerosis|September 24, 2004
In vivo administration of D-arginine: effects on blood pressure and vascular function in angiotensin II-induced hypertensive ratsGerald Wölkart, Heike Stessel, Friedrich Brunner
Pharmacological Research|April 4, 2006
Role of endogenous hydrogen peroxide in cardiovascular ischaemia/reperfusion function: studies in mouse hearts with catalase-overexpression in the vascular endotheliumGerald Wölkart, Gernot Kaber, Georg Kojda, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthaseBeatriz Pozo-Navas, Heike Stessel, Gerald Wölkart, et al.
Free Radical Biology & Medicine|October 27, 2009
Evidence against tetrahydrobiopterin depletion of vascular tissue exposed to nitric oxide/superoxide or nitroglycerinKurt Schmidt, Margit Rehn, Heike Stessel, et al.
European Journal of Pharmacology|January 22, 2005
Contractile action of levosimendan and epinephrine during acidosisWolfgang Toller, Gerald Wölkart, Christian Stranz, et al.
Molecular Pharmacology|April 19, 2002
Functional and analytical evidence for scavenging of oxygen radicals by L-arginineAchim Lass, Astrid Suessenbacher, Gerald Wölkart, et al.
British Journal of Pharmacology|May 17, 2006
Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthaseGerald Wölkart, Heike Stessel, Zora Saad, et al.
Cardiovascular Research|December 31, 2002
Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthaseFriedrich Brunner, Robert Maier, Penelope Andrew, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Cardiovascular Research|November 14, 2003
Peroxynitrite-induced cardiac depression: role of myofilament desensitization and cGMP pathwayFriedrich Brunner, Gerald Wölkart
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080)Friedrich Brunner, Gerald Wölkart, Stephen Haleen
Atherosclerosis|September 24, 2004
In vivo administration of D-arginine: effects on blood pressure and vascular function in angiotensin II-induced hypertensive ratsGerald Wölkart, Heike Stessel, Friedrich Brunner
Pharmacological Research|April 4, 2006
Role of endogenous hydrogen peroxide in cardiovascular ischaemia/reperfusion function: studies in mouse hearts with catalase-overexpression in the vascular endotheliumGerald Wölkart, Gernot Kaber, Georg Kojda, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthaseBeatriz Pozo-Navas, Heike Stessel, Gerald Wölkart, et al.
Free Radical Biology & Medicine|October 27, 2009
Evidence against tetrahydrobiopterin depletion of vascular tissue exposed to nitric oxide/superoxide or nitroglycerinKurt Schmidt, Margit Rehn, Heike Stessel, et al.
European Journal of Pharmacology|January 22, 2005
Contractile action of levosimendan and epinephrine during acidosisWolfgang Toller, Gerald Wölkart, Christian Stranz, et al.
Molecular Pharmacology|April 19, 2002
Functional and analytical evidence for scavenging of oxygen radicals by L-arginineAchim Lass, Astrid Suessenbacher, Gerald Wölkart, et al.
British Journal of Pharmacology|May 17, 2006
Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthaseGerald Wölkart, Heike Stessel, Zora Saad, et al.
Cardiovascular Research|December 31, 2002
Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthaseFriedrich Brunner, Robert Maier, Penelope Andrew, et al.
Pageof 4